FinnHubSpectral Medical to Present at the 3rd Annual H.C. Wainwright BioConnect Investor Conferenceabout 2 months ago
FinnHubSpectral Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 20252 months ago
FinnHubSpectral Medical Announces Fourth Quarter And Fiscal 2024 Results And Provides Corporate Update3 months ago
CashuSpectral Medical Inc. Files Shelf Prospectus to Enhance Financial Flexibility and Support Innovation3 days ago
CashuSpectral Medical Inc. Advances Leadership and Focus on Septic Shock Treatment Innovationsabout 1 month ago
CashuSpectral Medical Inc. Advances Sepsis Treatment with Toraymyxin™ Amid FDA Approval Effortsabout 2 months ago